Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Doxepin and Gabapentin in the Management of Uremic Pruritus
IRCT20250507065634N5Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of doxepin and gabapentin in chronic kidney disease-associated pruritus (CKD-aP) (2 arms), sponsored by Hormozgan University of Medical Sciences. Started Oct 2025; status: completed.
02
Drugs
doxepingabapentin
03
Conditions
chronic kidney disease-associated pruritus (CKD-aP)
Beyond the preview
Go deeper on IRCT20250507065634N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250507065634N5.